Institutional Career Development Core
机构职业发展核心
基本信息
- 批准号:10116515
- 负责人:
- 金额:$ 138.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-06-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AcademyClinicalClinical ResearchDental crownsDiverse WorkforceGenerationsGoalsGrantHealthInstitutesInternshipsLeadershipMentorsMentorshipMichiganPeer ReviewPrincipal InvestigatorPublicationsPublishingResearchTrainingTranslational Researchcareer developmentcohortexternshipimprovedprogramsresearch and developmentskillssupport network
项目摘要
The Michigan Institute for Clinical & Health Research (MICHR) recognizes the need for a highly-skilled, diverse
workforce that can conduct impactful clinical and translational research that improves health. Since the
inception of MICHR, the development of a diverse translational workforce has been a consistent priority. The
“crown jewel” of our efforts has been the KL2 program, which has attracted and developed exceptional
scholars. Since the inception of MICHR, KL2 scholars (n=36) have published >1,000 peer-reviewed
publications (median=21) and received >$155M in grant support as principal investigators (>$4 million per
scholar). Importantly, 97% of all KL2 graduates have remained in clinical and translational research and
85% of the 2006-2011 cohorts have been successfully promoted. We now propose to improve this program
with enhanced leadership skills through a new Career Development Academy, career development tracking
with electronic portfolios, formal mentorship training for KL2 mentors and scholars, expanded internship and
externship opportunities, and a stronger network of support as our KL2 scholars transition to independence.
MICHR’s goal is the creation of greater positive impact through training and mentoring a new generation of
KL2 scholars.
密歇根临床与健康研究所(MICHR)认识到对高技能、多样化的
能够进行有影响力的临床和转化性研究以改善健康的劳动力。自.以来
自MICHR成立以来,培养一支多样化的翻译队伍一直是一项一贯的优先事项。这个
我们努力的“皇冠上的明珠”是KL2计划,它吸引和发展了杰出的
学者。自MICHR成立以来,KL2学者(n=36)发表了1,000篇同行评议文章
出版物(中位数=21),作为主要研究人员获得1.55亿英镑的赠款支持(每项400万美元
学者)。重要的是,97%的KL2毕业生留在了临床和翻译研究领域,
在2006-2011年期间,85%的人员已成功晋升。我们现在建议改进这一计划
通过新的职业发展学院增强领导技能,职业发展跟踪
通过电子投资组合,为KL2导师和学者提供正式的导师培训,扩大实习和
外部机会,以及更强大的支持网络,因为我们的KL2学者过渡到独立。
MICHR的目标是通过培训和指导新一代
KL2学者。
项目成果
期刊论文数量(140)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A Care Coordination Intervention Improves Symptoms But Not Charges in High-Risk Patients With Inflammatory Bowel Disease.
- DOI:10.1016/j.cgh.2021.08.034
- 发表时间:2022-05
- 期刊:
- 影响因子:0
- 作者:Berinstein JA;Cohen-Mekelburg SA;Greenberg GM;Wray D;Berry SK;Saini SD;Fendrick AM;Adams MA;Waljee AK;Higgins PDR
- 通讯作者:Higgins PDR
End-Stage Kidney Disease and Dialysis in Pregnancy.
- DOI:10.1053/j.ackd.2020.06.001
- 发表时间:2020-11
- 期刊:
- 影响因子:2.9
- 作者:Oliverio AL;Hladunewich MA
- 通讯作者:Hladunewich MA
Factors affecting home delivery among women living in remote areas of rural Zambia: a cross-sectional, mixed-methods analysis.
- DOI:10.2147/ijwh.s169067
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Scott NA;Henry EG;Kaiser JL;Mataka K;Rockers PC;Fong RM;Ngoma T;Hamer DH;Munro-Kramer ML;Lori JR
- 通讯作者:Lori JR
Pharmacists providing care in statewide physician organizations: findings from the Michigan Pharmacists Transforming Care and Quality Collaborative.
- DOI:10.18553/jmcp.2020.26.12.1558
- 发表时间:2020-12
- 期刊:
- 影响因子:2.1
- 作者:Coe, Antoinette B.;Choe, Hae Mi;Diez, Heidi L.;Rockey, Nicole G.;Ashjian, Emily J.;Dorsch, Michael P.;Kim, Hyungjin Myra;Farris, Karen B.
- 通讯作者:Farris, Karen B.
Evaluation of Clinical Pharmacist Services in a Transitions of Care Program Provided to Patients at Highest Risk for Readmission.
- DOI:10.1177/0897190018806400
- 发表时间:2020-06
- 期刊:
- 影响因子:1.3
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VICKI L ELLINGROD其他文献
VICKI L ELLINGROD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VICKI L ELLINGROD', 18)}}的其他基金
CTSA Predoctoral T32 at the University of Michigan
CTSA 密歇根大学博士前 T32
- 批准号:
10620888 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
CTSA K12 Program at the University of Michigan
密歇根大学 CTSA K12 项目
- 批准号:
10621008 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
Development, Implementation and AssessMent of Novel Training in Domain-based Competencies (DIAMOND)
新型领域能力培训的开发、实施和评估(DIAMOND)
- 批准号:
9319951 - 财政年份:2017
- 资助金额:
$ 138.29万 - 项目类别:
Antipsychotic and Folate Pharmacogenetics - Gender Supplement
抗精神病药和叶酸药物遗传学 - 性别补充剂
- 批准号:
8797754 - 财政年份:2008
- 资助金额:
$ 138.29万 - 项目类别:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
叶酸药物基因组学和非典型抗精神病药代谢副作用的风险
- 批准号:
8019472 - 财政年份:2008
- 资助金额:
$ 138.29万 - 项目类别:
Folate Pharmacogenomics and Risk of Atypical Antipsychtoic Metabolic Side Effects
叶酸药物基因组学和非典型抗精神病药代谢副作用的风险
- 批准号:
8213443 - 财政年份:2008
- 资助金额:
$ 138.29万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 138.29万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 138.29万 - 项目类别: